According to NICE guidelines, it can be prescribed for adults with a BMI of 35 or above who have at least one obesity-related health condition (such as hypertension, sleep apnoea, or joint problems)
Sure, the people seeing these benefits in recent studies are largely the same ones who are already eligible for GLP-1s
Nausea, vomiting, and diarrhoeareported by a substantial proportion of patients, especially during treatment initiationresult in the loss of not only water but also essential electrolytes, particularly sodium, potassium, and chloride
Evaluation of aflatoxin B1 mutagenesis: addition of glutathione and [PMID: 3107976] Laboratory literature summary: Evaluation of aflatoxin B1 mutagenesis: addition of glutathione and glutathione-S-transferase to the Salmonella mutagenicity assay
As can be expected in the midst of an obesity epidemic, sales are rocketing